FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases
FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases
http://www.fda.gov/news-events/press-announcements/fda-launches-framework-accelerating-development-individualized-therapies-ultra-rare-diseases
Insufflation Unit Recall: Olympus Removes High Flow Insufflation Units
Early Alert: Trividia Health Issues Correction for TRUE METRIX Blood Glucose Monitoring Systems
Electronic Homecare Bed Correction: Medline Updates Use Instructions for Homecare Beds
FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
http://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
http://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-device-treat-pancreatic-cancer
Emergency Response Safety Kit Recall: Airlife Removes Certain Broselow Pediatric Emergency Rainbow Tapes and Broselow ALS Organizers
FDA Launches Assessment of BHA, a Common Food Chemical Preservative
FDA Launches Assessment of BHA, a Common Food Chemical Preservative
http://www.fda.gov/news-events/press-announcements/fda-launches-assessment-bha-common-food-chemical-preservative
FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
http://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs